TREATMENT OF OXIDATIVE STRESS DISORDERS

摘要

The use, in the treatment or prevention of ocular lens degeneration, corneal degeneration, skin degeneration or any ROS-induced degeneration of other tissues or organs characterised by the ER stress response, or in the preparation of a medicament for such degeneration treatment or prevention, of an active therapeutic agent comprising one or more sigma 1 receptor agonist.